Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk

Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk

Journal of the American Society of Nephrology

Saved in:
Bibliographic Details
Main Authors: Feldt-Rasmussen, B., Lange, M., Sulowicz, W., Gafter, U., Kar, N.L., Christiansen, J.S., Wiedemann, J., El, Nahas M., Sulkova, S., Madsen, M., Hannedouche, T., Lai, K.N., Holtzman, E., Schwartz, D., Katzir, Z., Weissgarten, J., Majdan, M., Niemczyk, S., Lee, K.O., Ahlmen, J., Mitra, S., Rodger, R.S.C., Tapson, J.S., Rustom, R., Ayub, W., Mikhail, A., Thomas, M.
Other Authors: MEDICINE
Format: Article
Published: 2011
Online Access:http://scholarbank.nus.edu.sg/handle/10635/26704
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/26704

Similar Items